Skip to main content
. Author manuscript; available in PMC: 2021 Dec 30.
Published in final edited form as: Am J Transplant. 2020 Mar 12;20(8):2101–2112. doi: 10.1111/ajt.15825

TABLE 3.

Likelihood of different transplant modalities among highly sensitized candidates by era and cPRA category

aSHR

Era 2 vs Era 11 Era 3 vs Era 11 Era 3 vs Era 21
Overall
 DDKT 0.971.041.12 1.74 1.85 1.97 1.67 1.77 1.89
 LDKT 0.861.001.16 0.991.131.30 0.991.131.30
  Non-KPD 0.65 0.78 0.94 0.69 0.82 0.97 0.871.041.25
  KPD 1.31 1.73 2.29 1.70 2.20 2.84 1.02 1.27 1.57
cPRA
 80%-89%
  DDKT 0.941.031.15 0.76 0.84 0.92 0.73 0.81 0.89
  LDKT 0.710.891.11 1.05 1.27 1.53 1.16 1.43 1.76
   Non-KPD 0.54 0.70 0.92 0.831.041.31 1.14 1.49 1.93
   KPD 1.02 1.53 2.29 1.41 2.03 2.91 0.951.331.85
 90%-97%
  DDKT 0.951.071.22 1.75 1.95 2.17 1.64 1.82 2.02
  LDKT 0.921.181.52 0.981.241.58 0.841.051.32
   Non-KPD 0.670.921.25 0.580.781.07 0.620.851.17
   KPD 1.25 1.98 3.13 1.71 2.62 4.00 0.941.321.86
 98%-99.9%
  DDKT 0.961.201.49 5.57 6.62 7.85 4.71 5.52 6.48
  LDKT 0.801.151.65 0.630.911.31 0.560.791.13
   Non-KPD 0.590.901.39 0.37 0.58 0.92 0.400.641.03
   KPD 1.05 2.21 4.66 1.14 2.32 4.73 0.611.051.81
 99.9%+
  DDKT 0.380.701.31 4.23 6.49 9.96 5.73 9.24 14.90
  LDKT 0.471.313.67 0.350.952.59 0.300.731.73
   Non-KPD 0.361.284.54 0.210.772.79 0.190.601.85
   KPD 0.241.377.99 0.271.336.68 0.240.973.93

Note: Bold indicates P < .05.

Abbreviations: aSHR, adjusted subhazard ratio; cPRA, calculated panel reactive antibody, DDKT, deceased donor kidney transplantation; KPD, kidney-paired donation; LDKT, living donor kidney transplantation.

1

Reference group.